Our dogs can offer us more than just companionship - they have an incredible ability to detect a range of illnesses in humans ...

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

“Identifying reliable biomarkers for Parkinson’s disease is essential to unlocking earlier diagnosis and more effective treatments. Grifols’ research on a plasma-based biomarker to detect PD ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

A new treatment is now available for people who have certain Parkinson’s Disease symptoms including medication-resistant ...

The latest update is out from Serina Therapeutics ( (SER) ).

"Parkinson's is complex and devastating, with no disease-modifying treatment options available for the millions of people impacted," commented Levi Garraway, Roche's chief medical officer and head ...